NCT05627466 2024-02-15US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid LeukemiaGilead SciencesNo longer available
NCT01200017 2021-05-27Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantUniversity of California, San FranciscoNo longer available
NCT03114228 2019-10-15An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)NovartisNo longer available
NCT03409081 2018-09-13Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)Astellas Pharma IncNo longer available
NCT00423826 2016-02-29Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseBarbara Ann Karmanos Cancer InstituteNo longer available